Alzamend Neuro Files 8-K on Shareholder Votes and Financials
Ticker: ALZN · Form: 8-K · Filed: Apr 25, 2025 · CIK: 1677077
| Field | Detail |
|---|---|
| Company | Alzamend Neuro, INC. (ALZN) |
| Form Type | 8-K |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financials, disclosure
Related Tickers: ALZN
TL;DR
ALZN filed an 8-K on 4/25/25 covering shareholder votes and financials.
AI Summary
Alzamend Neuro, Inc. filed an 8-K on April 25, 2025, reporting on matters submitted to a vote of security holders and financial statements. The company, incorporated in Delaware, is based in Atlanta, GA, and operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing provides updates on corporate governance and financial reporting, which are crucial for investors to assess the company's operational status and decision-making processes.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of corporate actions and financial information, not indicating immediate operational or financial distress.
Key Players & Entities
- Alzamend Neuro, Inc. (company) — Registrant
- April 25, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Atlanta, GA (location) — Principal executive offices
- 3480 Peachtree Road NE, Second Floor, Suite 103 (address) — Principal executive offices address
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What is the primary business of Alzamend Neuro, Inc.?
Alzamend Neuro, Inc. operates in the Pharmaceutical Preparations industry, as indicated by its Standard Industrial Classification code [2834].
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on April 25, 2025.
Where are Alzamend Neuro, Inc.'s principal executive offices located?
Alzamend Neuro, Inc.'s principal executive offices are located at 3480 Peachtree Road NE, Second Floor, Suite 103, Atlanta, GA 30326.
What is the SEC file number for Alzamend Neuro, Inc.?
The SEC file number for Alzamend Neuro, Inc. is 001-40483.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 25, 2025 regarding Alzamend Neuro, Inc. (ALZN).